Global law firm Baker McKenzie, which was recently awarded 2020 LMG Life Sciences Regulatory Firm to Watch, has added FDA regulatory lawyer Tiffany M. Humphries in Washington, DC, as the Firm continues to expand its market-leading food and drug law practice in North America.
Tiffany brings a deep knowledge of FDA regulation and policy after six and a half years working in the Office of the Chief Counsel at the FDA. In her previous role, she advised FDA's Centers for Foods Safety and Applied Nutrition and Drug Evaluation and Research on policy initiatives, rulemakings, enforcement matters, administrative hearings, cGMP compliance, technical assistance for Congress and a host of other key regulatory matters and initiatives. She joins the firm as a Senior Associate.
Baker McKenzie's Food and Drug Law Practice is chaired by Veleka Peeples-Dyer, a highly regarded food and drug regulatory and compliance lawyer with more than 20 years of experience providing strategic and practical business, legal and compliance counsel to a wide span of biopharmaceutical companies, including over 15 years of senior in-house counsel experience in leading biopharmaceutical companies. Veleka was short-listed for "FDA Attorney of the Year" in the LMG Awards in 2020 and is listed as a "LMG Life Sciences Star for FDA Regulatory: Pharmaceuticals."
Partner Khelin Aiken is also a key member of the Firm's Food and Drug Law Practice. Khelin is an experienced FDA attorney who leverages her deep understanding of the Food, Drug and Cosmetic Act, Public Health Service Act and their implementing regulations, along with her prior experience in private practice and at the FDA in the Center for Drug Evaluation and Research to help clients develop and achieve their strategic business objectives while providing key guidance on the commercial and regulatory factors impacting their business. Khelin was a finalist for the LMG 2020 FDA Rising Star Award.
The practice is focused on assisting clients with a broad range of regulatory, compliance, and enforcement matters impacting FDA-regulated products, including drugs, medical devices, food and cosmetics. Further, the practice provides regulatory expertise to support significant biopharmaceutical corporate transactions and litigation matters. "Our practice continues to grow as many of our life sciences clients around the world seek regulatory support to develop and bring innovative products to market." said North America Food and Drug Practice Chair, Veleka Peeples-Dyer. "The addition of Tiffany to our team further enhances the breadth and depth of our offerings to clients."
About Baker McKenzie's Food & Drug Law PracticeOur practitioners have extensive experience in FDA matters through their work in private practice, in-house at life sciences companies and within the FDA. The Baker McKenzie team understands the importance of providing practical and strategic legal advice that aligns with our clients’ business needs and compliance requirements. We routinely advise clients, from startups to global multinational companies, serving as key strategic legal and compliance advisors throughout a product's life cycle and on a variety of issues and concerns that life sciences companies face, all while keeping our clients apprised of significant regulatory, legislative and business developments around the globe.